Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Pantelis Litsardopoulos"'
Autor:
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Dimitrios Rikos, Georgia Xiromerisiou, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Publikováno v:
Toxins, Vol 16, Iss 2, p 106 (2024)
Background: We primarily aimed to ascertain whether treatment with OnabotulinumtoxinA (BoNTA) might influence the extent of the interictal burden and cutaneous allodynia in patients with chronic migraine (CM). Methods: Seventy CM patients, who receiv
Externí odkaz:
https://doaj.org/article/b931fb576d9b404e8011c5082a7dfa1a
Autor:
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Publikováno v:
European Journal of Neurology. 30:1435-1442
Autor:
Argyriou, Michail Vikelis, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Dimitrios Rikos, Andreas A.
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 13; Pages: 4526
Objective: this post hoc analysis aimed to evaluate the efficacy of fremanezumab in difficult-to-treat chronic migraine (CM) patients with and without psychiatric comorbidities (PCs), mainly anxiety and/or depression. Methods: We assessed data from C
Autor:
Andreas A. Argyriou, Emmanouil V. Dermitzakis, Georgia Xiromerisiou, Dimitrios Rallis, Panagiotis Soldatos, Pantelis Litsardopoulos, Michail Vikelis
Publikováno v:
Journal of Clinical Medicine; Volume 12; Issue 9; Pages: 3218
Objective: To define, in a real-world population of patients with high-frequency episodic (HFEM) or chronic migraine (CM), the predictive role of socio-demographic or phenotypic profiling of responders to fremanezumab. Patients and methods: Two-hundr
Autor:
Elisa Mantovani, Pantelis Litsardopoulos, Dimos-Dimitrios Mitsikostas, Stefano Tamburin, Vasileios Panagiotopoulos, Andreas A. Argyriou
Publikováno v:
Expert Review of Neurotherapeutics. 21:475-490
Post-traumatic headache (PTH), a common type of headache secondary to traumatic brain injury (TBI) or whiplash, carries a relevant burden on patients. PTH is still an undertreated condition because of limited pharmacological treatment options. Theref
Autor:
Andreas A. Argyriou, Haralabos P. Kalofonos, Foteini Kalofonou, Pantelis Litsardopoulos, Garifallia G Anastopoulou
Publikováno v:
Journal of the Peripheral Nervous System. 26:43-48
We investigated whether rechallenge with oxaliplatin (OXA) can worsen the pre-existing oxaliplatin-induced peripheral neurotoxicity (OXAIPN) in metastatic colorectal cancer (mCRC) patients. Patients previously treated with OXA, having clinically sign
Autor:
Jordi Bruna, Andreas A. Argyriou, Pantelis Litsardopoulos, Garifallia G Anastopoulou, Haralabos P. Kalofonos, Foteini Kalofonou, Dimitri Psimaras
Publikováno v:
Journal of the Peripheral Nervous System. 25:178-183
We report the outcome of a pilot, open-label study that tested the potential of lacosamide (200 mg/bi.d) as an effective and safe symptomatic treatment against acute painful oxaliplatin-induced peripheral neurotoxicity (OXAIPN). Lacosamide was introd
Autor:
Haralabos Anastogiannis, Nicholas G. Kounis, Andreas A. Argyriou, Andreas Petsas, Ifigenia Ravani, Garifallia G Anastopoulou, Grigorios Tsigkas, Pantelis Litsardopoulos
Publikováno v:
International Journal of Neuroscience. 130:746-748
We herein describe the unusual case of irreversible diffuse hypoxic-ischemic encephalopathy secondary to type I Kounis syndrome. The patient survived and remained in a vegetative state after being mechanically ventilated in the intensive care unit fo
Autor:
Andreas A. Argyriou, Elisa Mantovani, Michail Vikelis, Pantelis Litsardopoulos, Stefano Tamburin
Introduction: Although it causes a huge burden to sufferers, cluster headache (CH), remains an undertreated condition, partly due to the absence of established acute and prophylactic treatment opti...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::493778aa72676b57d4d4a87c6af4c1f3
http://hdl.handle.net/11562/1031158
http://hdl.handle.net/11562/1031158
Autor:
Konstantinos C. Spingos, Georgios S. Vlachos, Emmanouil V. Dermitzakis, Andreas A. Argyriou, Pantelis Litsardopoulos, Panagiotis Soldatos, Michail Vikelis, Evangelia Kararizou
Publikováno v:
Journal of Clinical Medicine
Volume 10
Issue 1
Journal of Clinical Medicine, Vol 10, Iss 67, p 67 (2021)
Volume 10
Issue 1
Journal of Clinical Medicine, Vol 10, Iss 67, p 67 (2021)
Background: To investigate the efficacy and safety of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 in episodic migraine (EM) prevention. Methods: A pilot, single-arm, open-label